0001209191-20-032486.txt : 20200527 0001209191-20-032486.hdr.sgml : 20200527 20200527213843 ACCESSION NUMBER: 0001209191-20-032486 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200525 FILED AS OF DATE: 20200527 DATE AS OF CHANGE: 20200527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arbet-Engels Christophe CENTRAL INDEX KEY: 0001802615 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35890 FILM NUMBER: 20916796 MAIL ADDRESS: STREET 1: C/O MILLENDO THERAPEUTICS, INC. STREET 2: 110 MILLER AVENUE, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Millendo Therapeutics, Inc. CENTRAL INDEX KEY: 0001544227 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 451472564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 MILLER AVENUE, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 BUSINESS PHONE: 734-845-9000 MAIL ADDRESS: STREET 1: 110 MILLER AVENUE, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 FORMER COMPANY: FORMER CONFORMED NAME: OvaScience, Inc. DATE OF NAME CHANGE: 20120308 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-25 0 0001544227 Millendo Therapeutics, Inc. MLND 0001802615 Arbet-Engels Christophe C/O MILLENDO THERAPEUTICS, INC. 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 2.00 2020-05-25 4 A 0 80000 0.00 A 2030-05-24 Common Stock 80000 80000 D Fifty percent (50%) of the shares subject to this option shall vest on the earlier of: (i) December 31, 2020 or (ii) the Board's approval of the achievement of certain performance criteria, and one twelfth (1/12th) of the remaining shares subject to this option shall vest in equal monthly installments thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each such date. /s/ Jason Minio, Attorney-in-Fact 2020-05-27